YungShin Global Holding Corporation (TPE:3705)

Market Cap	14.73B +5.7%
Revenue (ttm)	8.37B +7.1%
Net Income	963.10M -6.4%
EPS	3.62 -6.4%
Shares Out	266.36M
PE Ratio	15.29
Forward PE	n/a
Dividend	3.00 (5.42%)
Ex-Dividend Date	Jun 24, 2025

Volume	239,282
Average Volume	393,003
Open	55.20
Previous Close	55.20
Day's Range	54.80 - 55.40
52-Week Range	51.90 - 69.90
Beta	0.07
RSI	38.10
Earnings Date	Mar 30, 2026

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2024, YungShin Global Holding's revenue was 8.03 billion, an increase of 14.29% compared to the previous year's 7.03 billion. Earnings were 1.17 billion, an increase of 41.24%.